We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0T6G market cap is 0. The company's latest EPS is USD -3.9186 and P/E is -0.71.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.7M | 33.97M | 3.21M | 1.16M | 0 |
| Operating Income | -130.26M | -95.95M | -133.28M | -101.43M | -66.1M |
| Net Income | -128.69M | -95.76M | -5.01M | -112.96M | -47.73M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 263.74M | 211.72M | 228.47M | 84.56M | 92.33M |
| Total Liabilities | 67.74M | 42.07M | 50.49M | 11.57M | 86.66M |
| Total Equity | 196M | 169.65M | 177.98M | 72.99M | 5.68M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -94.33M | -109.75M | -113.66M | -96.23M | -67.72M |
| Investing | 204.9M | -50.79M | 36.72M | 101.33M | 19.93M |
| Financing | 53.09M | 52.17M | 596k | 184k | 95.14M |
| Market Cap | 0 |
| Price to Earnings Ratio | -0.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.43 |
| Price to Book Ratio | 5.97 |
| Dividend Yield | - |
| Shares Outstanding | 12.18M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Q32 Bio Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.q32bio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
